A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Latest Information Update: 06 Nov 2021
At a glance
- Drugs SLV 339 (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- Sponsors Abbott Healthcare Products
Most Recent Events
- 14 May 2014 New trial record